Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS)
CUSIP: 00461U105
Q2 2016 13F Holders as of 30 Jun 2016
- Type / Class
- Equity / Common Stock, $0.00001 par value per share
- Shares outstanding
- 121,058,810
- Total 13F shares
- 15,355,135
- Share change
- +722,806
- Total reported value
- $283,613,231
- Price per share
- $18.47
- Number of holders
- 47
- Value change
- +$13,304,019
- Number of buys
- 38
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 00461U105?
CUSIP 00461U105 identifies ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00461U105:
Top shareholders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
|
Company |
3.5%
|
4,191,397
|
$79,427,000 | — | 31 Mar 2016 | |
| FMR LLC |
13F
|
Company |
3.1%
|
3,804,279
|
$72,091,000 | — | 31 Mar 2016 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.2%
|
2,627,719
|
$49,795,000 | — | 31 Mar 2016 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.4%
|
1,639,454
|
$31,067,000 | — | 31 Mar 2016 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.74%
|
895,500
|
$16,970,000 | — | 31 Mar 2016 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.54%
|
647,944
|
$12,279,000 | — | 31 Mar 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.14%
|
169,296
|
$3,208,000 | — | 31 Mar 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.12%
|
146,957
|
$2,785,000 | — | 31 Mar 2016 | |
| TURNER INVESTMENTS LLC |
13F
|
Company |
0.07%
|
87,004
|
$1,649,000 | — | 31 Mar 2016 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
72,831
|
$1,379,000 | — | 31 Mar 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
57,351
|
$1,086,000 | — | 31 Mar 2016 | |
| NORGES BANK |
13F
|
Company |
0.04%
|
50,000
|
$948,000 | — | 31 Mar 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
43,246
|
$819,000 | — | 31 Mar 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
0.02%
|
28,286
|
$536,000 | — | 31 Mar 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.02%
|
20,419
|
$387,000 | — | 31 Mar 2016 | |
| Opaleye Management Inc. |
13F
|
Company |
0.01%
|
18,000
|
$341,000 | — | 31 Mar 2016 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
16,863
|
$320,000 | — | 31 Mar 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
15,521
|
$294,000 | — | 31 Mar 2016 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.01%
|
12,953
|
$245,000 | — | 31 Mar 2016 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
12,213
|
$231,000 | — | 31 Mar 2016 | |
| E. E. Geduld |
13F
|
Individual |
0.01%
|
10,771
|
$204,000 | — | 31 Mar 2016 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
8,490
|
$161,000 | — | 31 Mar 2016 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.01%
|
7,440
|
$141,000 | — | 31 Mar 2016 | |
| Nationwide Fund Advisors |
13F
|
Company |
0%
|
3,909
|
$74,000 | — | 31 Mar 2016 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
4,110
|
$64,000 | — | 31 Mar 2016 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0%
|
3,321
|
$63,000 | — | 31 Mar 2016 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0%
|
2,449
|
$46,000 | — | 31 Mar 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0%
|
1,937
|
$37,000 | — | 31 Mar 2016 | |
| STRS OHIO |
13F
|
Company |
0%
|
1,900
|
$36,000 | — | 31 Mar 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,858
|
$30,000 | — | 31 Mar 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
864
|
$16,000 | — | 31 Mar 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
614
|
$12,000 | — | 31 Mar 2016 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
349
|
$7,000 | — | 31 Mar 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
186
|
$4,000 | — | 31 Mar 2016 |
Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS) as of Q2 2016
As of 30 Jun 2016,
Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,355,135 shares.
The largest 10 holders included
Vivo Capital, LLC, FMR LLC, RA CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, Rock Springs Capital Management LP, Cormorant Asset Management, LLC, FIL Ltd, VANGUARD GROUP INC, BlackRock Fund Advisors, and STATE STREET CORP.
This page lists
47
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2016 vs Q1 2016 Across Filers
Q1 2016 holders
34
Q2 2016 holders
47
Holder diff
13
| Investor | Q1 2016 Shares | Q2 2016 Shares | Share Diff | Share Chg % | Q1 2016 Value $ | Q2 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.